HEALTHJul 1 · 08:50 UTCNPR HEALTHSydney Lupkin

Medicare offers access to popular obesity drugs for $50 a month

Medicare is providing beneficiaries access to popular obesity drugs with a $50 monthly copay. The program requires patients to meet specific criteria and is a temporary initiative set to last through 2027.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

Medicareorganizationobesity drugstopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHMay 6 · 09:00 UTC
A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
HEALTHJun 30 · 22:31 UTC
Medicare rolls out $50 GLP-1 drugs. ‘Pandemonium’ ahead for Michigan doctors?
HEALTHJun 16 · 09:30 UTC
Up to 14M Medicare patients could be eligible for GLP-1s for just $50 a month — here’s who qualifies
HEALTHJun 15 · 15:25 UTC
STAT+: Trump’s obesity drug plan creates a temporary Medicare program that may be hard to end